Stanek KR, et al. - In this investigation, researchers identified the prevalence of autism spectrum disorder (ASD) in a clinic population of pediatric type 1 diabetes (T1D) and the clinical features and technology used by people with both ASD and T1D vs the overall pediatric T1D clinic alone and matched T1D controls. Review of medical charts showed 30 people with ASD as well as T1D (ASD + T1D). They matched 90 controls for age, sex, race/ethnicity, and period of T1D. Data reported that the prevalence of ASD in the clinic’s population of pediatric T1D patients was 1.16%. Findings revealed that ASD + T1D had more males, lower hemoglobin A1c (HbA1c), and lower insulin pump (CSII) use vs the T1D clinic population. In the pediatric T1D population, the prevalence of ASD is similar to the general population in Colorado. People with ASD may experience barriers that limit CSII use but achieve glycemic control equivalent to those without ASD. In maintaining lower HbA1c over time, CSII might be more effective in those with ASD than in those without ASD.